Sanofi-Aventis Sues Sandoz Over Taxotere Drug Patent

Law360, New York (October 30, 2009, 12:56 PM EDT) -- Sanofi-Aventis is seeking to protect its flagship cancer treatment drug Taxotere in a lawsuit against generics maker Sandoz Inc., alleging Sandoz's abbreviated new drug application with the U.S. Food and Drug Administration violates Sanofi's patents.

Sanofi filed its complaint Thursday in the U.S. District Court for the District of Delaware, saying Sandoz wants to make its generic version of Taxotere before Sanofi's three patents expire.

The lawsuit comes the same week as a bench trial in a consolidated action where Sanofi also accused drugmakers Hospira Inc....
To view the full article, register now.